Fisher Research Development vs Other Operating Expenses Analysis

FPH Stock

33.55 0.13 0.39%

Fisher Paykel financial indicator trend analysis is much more than just examining Fisher Paykel Healthcare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fisher Paykel Healthcare is a good investment. Please check the relationship between Fisher Paykel Research Development and its Other Operating Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Other Operating Expenses

Research Development vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fisher Paykel Healthcare Research Development account and Other Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Fisher Paykel's Research Development and Other Operating Expenses is 0.98. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Fisher Paykel Healthcare, assuming nothing else is changed. The correlation between historical values of Fisher Paykel's Research Development and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Fisher Paykel Healthcare are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Research Development i.e., Fisher Paykel's Research Development and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Fisher Paykel Healthcare. It is also known as Fisher Paykel overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from Fisher Paykel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fisher Paykel Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Fisher Paykel's Discontinued Operations is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 517.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	938.7M	885.3M	1.0B	1.1B
Total Revenue	1.5B	1.5B	1.7B	1.8B

Gross Profit Total Revenue

Fisher Paykel fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.98	0.92	1.0	0.4	0.99	0.49	0.93	0.23	-0.3	0.9	-0.29	0.97	0.3	0.93	-0.36	-0.23	0.96	0.23	0.99	0.72	0.97	-0.07	0.16	0.98	0.6
Other Current Liab	0.98		0.9	0.97	0.36	0.98	0.4	0.89	0.14	-0.34	0.9	-0.33	0.95	0.28	0.91	-0.33	-0.23	0.9	0.27	0.98	0.72	0.97	-0.15	0.17	0.98	0.67
Total Current Liabilities	0.92	0.9		0.89	0.47	0.89	0.54	0.83	0.26	-0.34	0.94	-0.3	0.82	0.16	0.98	-0.25	-0.07	0.9	0.45	0.89	0.68	0.88	0.13	0.12	0.89	0.6
Total Stockholder Equity	1.0	0.97	0.89		0.38	1.0	0.47	0.93	0.23	-0.3	0.87	-0.29	0.97	0.29	0.9	-0.39	-0.28	0.95	0.17	0.99	0.71	0.97	-0.1	0.16	0.98	0.59
Other Liab	0.4	0.36	0.47	0.38		0.35	0.71	0.46	-0.04	-0.71	0.53	-0.15	0.25	-0.24	0.45	-0.52	0.0	0.37	0.16	0.4	0.5	0.42	-0.08	0.37	0.44	0.05
Net Tangible Assets	0.99	0.98	0.89	1.0	0.35		0.42	0.92	0.22	-0.3	0.88	-0.33	0.97	0.29	0.9	-0.38	-0.24	0.94	0.21	0.99	0.73	0.98	-0.12	0.19	0.99	0.64
Accounts Payable	0.49	0.4	0.54	0.47	0.71	0.42		0.59	0.31	-0.26	0.5	0.21	0.38	-0.07	0.52	-0.26	-0.42	0.61	-0.07	0.4	0.12	0.36	0.21	-0.21	0.41	-0.19
Cash	0.93	0.89	0.83	0.93	0.46	0.92	0.59		0.3	-0.29	0.81	-0.13	0.91	0.31	0.83	-0.3	-0.4	0.94	0.04	0.9	0.56	0.87	-0.04	-0.02	0.9	0.35
Other Assets	0.23	0.14	0.26	0.23	-0.04	0.22	0.31	0.3		0.06	0.0	0.09	0.28	0.01	0.21	-0.12	-0.32	0.45	-0.37	0.11	-0.06	0.07	0.66	-0.19	0.12	-0.26
Long Term Debt	-0.3	-0.34	-0.34	-0.3	-0.71	-0.3	-0.26	-0.29	0.06		-0.49	0.36	-0.17	0.58	-0.26	0.58	0.09	-0.21	-0.09	-0.34	-0.47	-0.4	0.17	-0.53	-0.39	-0.32
Net Receivables	0.9	0.9	0.94	0.87	0.53	0.88	0.5	0.81	0.0	-0.49		-0.28	0.77	0.04	0.92	-0.29	-0.12	0.81	0.41	0.9	0.71	0.9	-0.07	0.19	0.9	0.68
Good Will	-0.29	-0.33	-0.3	-0.29	-0.15	-0.33	0.21	-0.13	0.09	0.36	-0.28		-0.26	0.12	-0.25	0.47	-0.32	-0.13	-0.41	-0.37	-0.63	-0.41	0.25	-0.69	-0.38	-0.54
Inventory	0.97	0.95	0.82	0.97	0.25	0.97	0.38	0.91	0.28	-0.17	0.77	-0.26		0.42	0.84	-0.31	-0.28	0.93	0.13	0.95	0.65	0.93	-0.13	0.09	0.94	0.55
Other Current Assets	0.3	0.28	0.16	0.29	-0.24	0.29	-0.07	0.31	0.01	0.58	0.04	0.12	0.42		0.27	0.11	0.04	0.27	0.03	0.3	0.19	0.27	0.06	-0.13	0.27	0.07
Total Liab	0.93	0.91	0.98	0.9	0.45	0.9	0.52	0.83	0.21	-0.26	0.92	-0.25	0.84	0.27		-0.23	0.0	0.89	0.45	0.91	0.73	0.89	0.09	0.15	0.9	0.62
Long Term Investments	-0.36	-0.33	-0.25	-0.39	-0.52	-0.38	-0.26	-0.3	-0.12	0.58	-0.29	0.47	-0.31	0.11	-0.23		0.19	-0.32	0.29	-0.39	-0.61	-0.44	-0.01	-0.75	-0.45	-0.1
Short Long Term Debt	-0.23	-0.23	-0.07	-0.28	0.0	-0.24	-0.42	-0.4	-0.32	0.09	-0.12	-0.32	-0.28	0.04	0.0	0.19		-0.36	0.68	-0.16	0.31	-0.13	-0.14	0.44	-0.17	0.32
Total Current Assets	0.96	0.9	0.9	0.95	0.37	0.94	0.61	0.94	0.45	-0.21	0.81	-0.13	0.93	0.27	0.89	-0.32	-0.36		0.07	0.9	0.56	0.87	0.12	-0.01	0.9	0.39
Short Term Debt	0.23	0.27	0.45	0.17	0.16	0.21	-0.07	0.04	-0.37	-0.09	0.41	-0.41	0.13	0.03	0.45	0.29	0.68	0.07		0.28	0.39	0.29	-0.21	0.16	0.25	0.65
Property Plant Equipment	0.99	0.98	0.89	0.99	0.4	0.99	0.4	0.9	0.11	-0.34	0.9	-0.37	0.95	0.3	0.91	-0.39	-0.16	0.9	0.28		0.79	1.0	-0.18	0.26	1.0	0.69
Short Long Term Debt Total	0.72	0.72	0.68	0.71	0.5	0.73	0.12	0.56	-0.06	-0.47	0.71	-0.63	0.65	0.19	0.73	-0.61	0.31	0.56	0.39	0.79		0.83	-0.19	0.76	0.81	0.71
Property Plant And Equipment Net	0.97	0.97	0.88	0.97	0.42	0.98	0.36	0.87	0.07	-0.4	0.9	-0.41	0.93	0.27	0.89	-0.44	-0.13	0.87	0.29	1.0	0.83		-0.2	0.33	1.0	0.72
Current Deferred Revenue	-0.07	-0.15	0.13	-0.1	-0.08	-0.12	0.21	-0.04	0.66	0.17	-0.07	0.25	-0.13	0.06	0.09	-0.01	-0.14	0.12	-0.21	-0.18	-0.19	-0.2		-0.18	-0.17	-0.33
Net Debt	0.16	0.17	0.12	0.16	0.37	0.19	-0.21	-0.02	-0.19	-0.53	0.19	-0.69	0.09	-0.13	0.15	-0.75	0.44	-0.01	0.16	0.26	0.76	0.33	-0.18		0.3	0.43
Non Current Assets Total	0.98	0.98	0.89	0.98	0.44	0.99	0.41	0.9	0.12	-0.39	0.9	-0.38	0.94	0.27	0.9	-0.45	-0.17	0.9	0.25	1.0	0.81	1.0	-0.17	0.3		0.67
Non Currrent Assets Other	0.6	0.67	0.6	0.59	0.05	0.64	-0.19	0.35	-0.26	-0.32	0.68	-0.54	0.55	0.07	0.62	-0.1	0.32	0.39	0.65	0.69	0.71	0.72	-0.33	0.43	0.67

Click cells to compare fundamentals

Fisher Paykel Account Relationship Matchups

Fisher Paykel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.4B	1.9B	2.0B	2.1B	2.3B	2.4B
Other Current Liab	133.4M	178.9M	181.1M	219.3M	256.4M	269.2M
Total Current Liabilities	324.1M	393.1M	281.5M	271.2M	385M	404.3M
Total Stockholder Equity	943.2M	1.4B	1.6B	1.6B	1.8B	1.8B
Other Liab	81M	33.9M	36.1M	36.8M	42.3M	32.8M
Net Tangible Assets	899.9M	1.4B	1.6B	1.7B	1.9B	2.0B
Accounts Payable	67.1M	52.1M	53.8M	43M	32.4M	30.0M
Cash	65.0M	89.5M	83.3M	113.3M	82M	86.1M
Long Term Debt	22M	62.8M	63M	79.1M	35.7M	44.5M
Net Receivables	216.3M	210.5M	142.8M	179.6M	257.2M	270.1M
Inventory	141.9M	248.8M	332.4M	342.4M	320.4M	336.4M
Other Current Assets	4.0M	39.4M	30.7M	107.3M	45.3M	25.6M
Total Liab	446.7M	509.5M	395.8M	422.2M	522.6M	548.7M
Short Long Term Debt	80.6M	11.9M	5.3M	4.2M	78.5M	82.4M
Total Current Assets	502.4M	846.0M	822.4M	724.6M	704.9M	740.1M
Short Term Debt	89.3M	24.5M	17M	21.3M	96.2M	101.0M
Property Plant Equipment	735.3M	882.1M	957.8M	1.1B	1.3B	1.4B
Short Long Term Debt Total	133.3M	116.3M	96.6M	136.5M	189.1M	198.6M
Property Plant And Equipment Net	712.2M	811.1M	887.2M	1.1B	1.3B	1.4B
Current Deferred Revenue	34.3M	137.6M	29.5M	6.2M	7.1M	6.7M
Net Debt	66.9M	19.4M	13.3M	23.2M	107.1M	112.5M
Non Current Assets Total	887.6M	1.1B	1.1B	1.3B	1.6B	1.7B
Cash And Short Term Investments	140.3M	347.2M	268.5M	113.3M	82M	79.7M
Common Stock Total Equity	198.4M	219.2M	225.4M	249.1M	286.5M	156.1M
Liabilities And Stockholders Equity	1.4B	1.9B	2.0B	2.1B	2.3B	2.4B
Non Current Liabilities Total	122.6M	116.4M	114.3M	151.0M	137.6M	79.8M
Property Plant And Equipment Gross	735.3M	882.1M	1.4B	1.6B	1.9B	2.0B
Common Stock	221.8M	231.1M	246.7M	287.3M	404M	424.2M
Retained Earnings	664.8M	946.4M	1.1B	1.1B	1.1B	1.1B
Other Stockholder Equity	(3.5M)	(2.0M)	(123.8M)	(112.3M)	(101.0M)	(96.0M)
Accumulated Other Comprehensive Income	60.2M	223.1M	219.8M	233.2M	260.1M	273.1M
Intangible Assets	71.6M	73.6M	80.4M	80.1M	88.4M	92.8M
Short Term Investments	75.3M	257.7M	185.3M	500K	575K	546.3K
Long Term Debt Total	52.5M	69M	44M	91.8M	105.6M	63.1M
Treasury Stock	(3M)	(1.8M)	(3.6M)	(2.2M)	(2.0M)	(2.1M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fisher Stock Analysis

When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC